Download or read book Glycan and Glycosylation as a Target for Treatment of Glioblastoma written by Atit Silsirivanit and published by . This book was released on 2022 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Glycosylation is an important post-translational modification regulating many cellular processes. In cancer, aberrant glycosylation leads to the expression of tumor-associated glycans that are possibly used as therapeutic targets or biomarkers for diagnosis, monitoring, and prognostic prediction. The cumulative evidence suggested the significance of alteration of glycosylation in glioblastoma (GBM). Aberrant glycosylation presents truncated or uncommon glycans on glycoproteins, glycolipids, and other glycoconjugates. These aberrant glycans consequently promote the tumor development, metastasis, and therapeutic resistance. The glycosylation changes occurred in either cancer cells or the tumor microenvironment. GBM-associated glycans and their corresponding enzymes are proposed to be a target for GBM treatment. Several tools, such as lectin and inhibitors, are possibly applied to target the tumor-associated glycans and glycosylation for the treatment of GBM. This chapter provides information insight into glycosylation changes and their roles in the development and progression of GBM. The perspectives on targeting glycans and glycosylation for the treatment of GBM are enclosed.